Epithalon
A telomerase-activating peptide that extends telomeres and reverses senescence markers—backed by 25+ years of clinical use in Russia.
Also known as: Epitalon, AEDG Tetrapeptide
Available on Forge Amino
Epithalon 50MG — independently lab tested, 99%+ purity, QR-linked COA.
Important: This content is for informational and research purposes only and is not intended for human or veterinary use. Consult your physician for health-related guidance and laboratory monitoring.
How It Works
Activates telomerase (hTERT subunit), extending telomere length in somatic cells. Restores melatonin and supports neuroendocrine function; reverses some senescence markers.
Key Benefits
- ✓Measurable telomere lengthening
- ✓Reversal of replicative senescence
- ✓Restored melatonin secretion
- ✓Improved lipid and inflammatory markers
- ✓Enhanced cognitive and physical function
Dosing Protocols
Beginner / Intermediate
Dose
5 mg
Frequency
Daily for 10 days
Cycle Length
1-2 weeks per course
Notes
Repeat every 3-6 months
Advanced
Dose
10 mg
Frequency
Daily for 20 days
Cycle Length
4 weeks per course
Notes
Repeat 2x per year; cyclic low-dose more effective than continuous
Side Effects & Safety
Common Side Effects
- Minimal; excellent 15+ year safety data
- Rare: mild injection site reactions
- Anecdotal: transient sleep disruption
- No serious toxicity or malignancy acceleration
Contraindications
- Active malignancy
- Recent cancer history (<5 years, relative)
- Pregnancy and breastfeeding
Stacking & Synergies
These compounds have complementary mechanisms and may enhance results when used together.
Key Takeaway
Reset your biological clock: Epithalon activates telomerase to add years to your cells' lifespan.
Research Disclaimer: This content is for informational and research purposes only. It is not medical advice. These products are not approved by the FDA for human consumption. Consult a qualified healthcare provider before starting any new protocol. The information provided is based on preclinical research and anecdotal reports and has not been formally evaluated in randomized controlled trials.